Methods of Treating Cancer Using Antibodies and Molecules That Immunospecifically Bind to BTN1A1
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,875,920 | Antibodies and Molecules That Immunospecifically Bind to BTN1A1 and the Therapeutic Uses Thereof In force · High confidence | Board of Regents, the University of Texas System | In force | High confidence | ||
| US 11,970,534 | Antibodies and Molecules That Immunospecifically Bind to BTN1A1 and the Therapeutic Uses Thereof In force · High confidence | Board of Regents, the University of Texas System | In force | High confidence | ||
| US 11,542,331 | Methods of Treating Cancer Using Antibodies and Molecules That Bind to BTN1A1 or BTN1A1-LIGANDS In force · High confidence | Stcube & Co., Inc. | In force | High confidence | ||
| US 12,215,151 | Methods of Treating Cancer Using Antibodies and Molecules That Immunospecifically Bind to BTN1A1 In force · High confidence | Stcube & Co., Inc. | In force | High confidence | ||
| Application 15/575,325 | Screening Methods for Targets for Cancer Therapy Abandoned Abandoned Jul 7, 2025 | Board of Regents, the University of Texas System | Abandoned | Abandoned Jul 7, 2025 | ||
| Application 16/618,042 | Antibodies and Molecules That Immunospecifically Bind to BTN1A1 and the Therapeutic Uses Thereof Abandoned Abandoned Nov 15, 2024 | Stcube & Co., Inc. | Abandoned | Abandoned Nov 15, 2024 | ||
| Application 18/066,879 | Methods of Treating Cancer Using Antibodies and Molecules That Bind to BTN1A1 or BTN1A1-LIGANDS Pending Not granted | Stcube & Co., Inc. | Pending | Not granted | ||
| Application 18/625,891 | Antibodies and Molecules That Immunospecifically Bind to BTN1A1 and the Therapeutic Uses Thereof Pending Not granted | Board of Regents, the University of Texas System | Pending | Not granted | ||
| Application 18/763,821 | Antibodies and Molecules That Immunospecifically Bind to BTN1A1 and the Therapeutic Uses Thereof Pending Not granted | Stcube & Co., Inc. | Pending | Not granted | ||
| Application 18/847,179 | BTN1A1 Binding Proteins and Methods of Use Thereof Pending Not granted | Stcube & Co., Inc. | Pending | Not granted | ||
| 2 more patents in this group · Pro | ||||||
10 of 12 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 12.
2 of these are in force and held by Stcube & Co., Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.